Blogger ‘Sang Kelembai’ charged with making offensive post on vaccine procurement

KUALA LUMPUR: Blogger "Sang Kelembai" pleaded not guilty at the Sessions Court here Wednesday (Jan 31) to a charge of making an offensive post about vaccine procurement matters on his Facebook page four years ago. Datuk Abd Zarin Mohd Yasin, 72, was charged with creating and initiating the transmission of offensive communications with intent to annoy...

Health Ministry: 234 vaccination centres nationwide offer Covid-19 vaccines

PETALING JAYA: There are 234 vaccination centres (PPV) available in health clinics nationwide, says the Health Ministry. The ministry said the people can access the full list of the PPV through the MySejahtera application. “The public can walk-in to the nearest PPV or make an appointment first through the MySejahtera app to receive the Covid-19 vaccine. All...

Govt must prepare sufficient vaccines as Covid-19 cases continue to rise, says KJ

ISKANDAR PUTERI: A sufficient supply of vaccines must be prepared by the government to safeguard Malaysians against the rising cases of Covid-19, says a former health minister. Khairy Jamaluddin said that early preparations must be made to ensure that the increasing cases do not put strain on the Health Ministry in terms of bed capacity and...

Covid-19 vaccine doses worth RM505mil expired as of June 1, PAC says

PETALING JAYA: A total of 8.5 million Covid-19 vaccine doses worth RM505mil have expired as of June 1, the Public Accounts Committee (PAC) report on the management of the Covid-19 outbreak has revealed. The Health Ministry had procured vaccines based on its projections on the number of doses needed but decreased demand for vaccination, delay in...

MOH: Those on Sinovac, Sinopharm must get 3rd jab to be considered fully vaccinated

Some 70,000 people who took two Sinovac or Sinopharm jabs have till Dec 31 to get their third dose in order to keep their fully vaccinated status from Jan 1, while the grace period for children turning 13 next year to get fully vaccinated has been extended by two months to March 1. The Ministry of Health...

Sinovac for 3-year-olds? Hong Kong parents should have BioNTech option as well, pharmacists group chief says

Hong Kong parents should also have the option of BioNTech jabs for their younger children, the head of the city's pharmacists association has suggested ahead of a Monday (Nov 15) meeting expected to determine if children as young as three will be allowed to take the Sinovac vaccine. Sinovac's mainland Chinese manufacturer last month applied to...

The United States Opens Its Borders To Fully Vaccinated Travellers Without Quarantine

More countries are reopening their borders to international tourists following the progress of the worldwide vaccination rates.  After shutting its border closed for nearly 20 months, the United States of America (USA) has now opened its door to international travellers, including from Malaysia. Of course, you have to be fully vaccinated to travel abroad. According to BFM News, The US Embassy in...

Moderna struggles with vaccine ramp-up, cuts 2021 sales view

Moderna Inc on Thursday (Nov 4) slashed the 2021 sales forecast for its Covid-19 vaccine by as much as $5 billion (S$6.7 billion), grappling to fill vials and distribute them to meet unprecedented world demand, sending its shares tumbling 16 per cent. Moderna executives said production challenges now lie with bottling up doses, also known as...

Pfizer/BioNTech Covid-19 vaccine highly protective in 12-18 age group: US CDC study

The Pfizer/BioNTech vaccine is authorised for children as young as 12, and the companies are seeking authorisation for use in those as young as five years of age.Reuters WASHINGTON - The Pfizer/BioNTech Covid-19 vaccine was 93 per cent effective in preventing hospitalisations among those aged 12 to 18, according to an analysis released by the US Centres...

Covid-19 pill developers aim to top Merck, Pfizer efforts

An experimental Covid-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP.Reuters file As Merck & Co and Pfizer Inc prepare to report clinical trial results for experimental Covid-19 antiviral pills, rivals are lining up with what they hope will prove to be more potent and convenient oral treatments of their...